[1]
Emmanouilides, C. 2009. Target long-term responders in indolent non-Hodgkin’s lymphoma: 90Y-ibritumomabtiuxetan. Hematology Meeting Reports (formerly Haematologica Reports). 2, 7 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v2i7.396.